Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
516 News Releases found
MSK’s Robert Motzer, MD
Positive Data from Randomized Phase III Study Suggests That a Combination of Immunotherapy Drugs Can Help Some People with Advanced Kidney Cancer

Memorial Sloan Kettering Cancer Center (MSK) researchers presented the results of a randomized phase III trial at today’s press program for the European Society for Medical Oncology’s 2018 Congress in Munich, Germany. The results demonstrated that a combination of the immune checkpoint blocker avelumab (Bavencio®) and the tyrosine kinase inhibitor (TKI) axitinib (Inlyta®) can significantly improve progression-free survival (PFS) in people who have been previously untreated for advanced renal cell carcinoma (RCC).
MSK’s Beryl McCormick, MD
Whole Breast Radiation Found to Reduce Local Recurrence Following Surgery in Women with “Good Risk” DCIS

Whole breast radiation (WBRT) significantly reduced local recurrence in women with “good risk” (low risk) ductal carcinoma in situ (DCIS) following breast conservation surgery, according to researchers from Memorial Sloan Kettering Cancer Center, who presented this data in a press conference at the annual meeting of the American Society for Radiation Oncology (ASTRO).
MSK Radiologist Named Winner of National Academy of Medicine's David Rall Medal

The National Academy of Medicine (NAM) has named Hedvig Hricak, MD, PhD, Chair of the Department of Radiology, a recipient of the David Rall Medal. The medal is given annually to a NAM member who has demonstrated outstanding leadership. Dr. Hricak received the award at the 2018 NAM Annual Meeting on Monday, October 15, 2018, in Washington, D.C.
Memorial Sloan Kettering Announces Policy Changes

Memorial Sloan Kettering shares results of a recent review by our Boards of Overseers and Managers, as well as additional policies we are considering to enhance communication, transparency, disclosure, and oversight of outside activities and industry-supported clinical trials.
Memorial Sloan Kettering and Paige.AI

MSK was recently in the news regarding our relationship with a technology spin-off company called Paige.AI.
Memorial Sloan Kettering Cancer Center Announces Conflict of Interest Task Force

Today Memorial Sloan Kettering (MSK) announced the appointment of a task force that will assess MSK policies and processes for reporting and managing outside activities and industry-supported clinical trials.
Ralph Lauren Center for Cancer Care to Formally Join Memorial Sloan Kettering

The Ralph Lauren Center for Cancer Care, a Harlem-based cancer prevention and treatment program, is expected to more closely align with Memorial Sloan Kettering Cancer Center (MSK) in 2019 pending the approval of the New York State Department of Health and other state agencies. The filing deepens the longstanding partnership between MSK and the Ralph Lauren Center. 
Kenneth Manotti, Senior Vice President and Chief Development Officer at MSK
Kenneth Manotti Named Senior Vice President and Chief Development Officer at Memorial Sloan Kettering Cancer Center

Kenneth Manotti has been named Senior Vice President and Chief Development Officer at Memorial Sloan Kettering Cancer Center (MSK).
J. Ted Gerstle
Renowned Pediatric Surgeon J. Ted Gerstle Named Chief of the Pediatric Surgery Service at Memorial Sloan Kettering Cancer Center

Pediatric surgeon J. Ted Gerstle, MD, FACS, FRCS, has been named the new Chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK).
Kreg Koford Joins Memorial Sloan Kettering as Senior Vice President of Supply Chain and Sustaining Care Services

Memorial Sloan Kettering Cancer Center (MSK) has announced that Kreg Koford has been named MSK's Senior Vice President of Supply Chain and Sustaining Care Services. Mr. Koford assumes his new role at MSK on July 9, 2018.